Abstract
Seizures are a common presentation of brain neoplasms. Both primary brain tumors and metastases can present with seizures, which are more commonly focal depending on the location and the pathology of the lesion. In general, more benign tumors have higher incidence of seizures than more malignant ones. These patients are admitted to an intensive care unit either for preoperative monitoring or in the postoperative period. They should be treated with antiepileptics if seizures are witnessed. Whether they should be prophylactically treated with antiepileptic medications if seizures have not occurred yet in the pre- and postoperative period, and for how long, are questions that remain to be answered. More recent data do not seem to support such prophylactic administration.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Ziai WC, Varelas PN, Zeger SL, Mirski MA, Ulatowski JA. Neurologic intensive care resource use after brain tumor surgery: an analysis of indications and alternative strategies. Crit Care Med 2003;31:2782–2787.
LeBlanc F, Rasmussen T. Cerebral seizures and brain tumors. In: Vinken PJ, Bruyn GW, eds. Handbook of Clinical Neurology. Amsterdam: Elsevier Science Publishers: 1974:295–301.
Cascino G. Epilepsy and brain tumors: implications for treatment. Epilepsia 1990;31(suppl 3): S37–S44.
Bartolomei J, Christopher S, Vives K, Spencer DD, Piepmeier JM. Low grade gliomas of chronic epilepsy: a distinct clinical and pathological entity. J Neurooncol 1997;34:79–84.
McKeran R, Thomas DGT. The clinical study of gliomas. In: Thomas D, Graham DL, eds. Brain Tumors: Scientific Basis, Clinical Investigation and Current Therapy. Baltimore: 1980:194–230.
Cohen N, Strauss G, Lew R, Silver R, Recht L. Should prophylactic anticonvulsants be administered to patients with newly diagnosed cerebral metastases? A retrospective analysis. J Clin Oncol 1988;6:1621–1624.
Simonescu M. Metastatic tumors of the brain. A follow-up study of 195 patients with neurosurgical considerations. J Neurosurg 1960;17:361–373.
Ketz E. Brain tumors and epilepsy. In: Vinken P, Bruyn GW, eds. Handbook of Clinical Neurology.Amsterdam: Elsevier Science Publishers: 1974:254–269.
Moots P, Maciunas RJ, Eisert DR, Parker RA, Laporte K, Abou-Khalil B. The course of seizure disorders in patients with malignant gliomas. Arch Neurol 1995;52:717–724.
Whittle I, Beaumont A. Seizures in patients with supratentorial oligodendroglial tumours; clinicopathological features and management considerations. Acta Neurochir (Wien) 1995;135:19–24.
Rasmussen T, Blundell J. Epilepsy and brain tumours. Clin Neurosurg 1959;7:138–158.
Hoefer P, Schlesinger EB, Peress HH. Seizures in patients with brain tumours. Res Nerv Ment Dis Proc 1947;26:50–58.
Morris H, Estes ML, Prayson RA, et al. Frequency of different tumor types encountered in the Cleveland Clinic epilepsy surgery program. Epilepsia 1996;37:96.
Beaumont A, Whittle IR. The pathogenesis of tumour associated epilepsy. Acta Neurochir (Wien) 2000; 142:1–15.
Scott G, Gibberd FB. Epilepsy and other factors in the prognosis of gliomas. Acta Neurol Scand 1980; 61:227–239.
Mahaley MJ, Dudka L. The role of anticonvulsant medications in the management of patients with anaplastic gliomas. Surg Neurol 1981;16:399–401.
Victor M, Ropper AH. Principles of Neurology. New York: McGraw-Hill: 2001.
Kvam D, Loftus CM, Copeland B, Quest DO. Seizures during the immediate postoperative period. Neurosurgery 1983;12:14–17.
Lee S, Lui TN, Chang CN, Cheng WC. Early postoperative seizures after posterior fossa surgery. J Neurosurg 1990;73:541–544.
North JB, Penhall RK, Hanieh A, Frewin DB, Taylor WB. Phenytoin and postoperative epilepsy—a double blind study. J Neurosurg 1983;58:672–677.
Fukamachi A, Koizumi H, Nukui H. Immediate postoperative seizures—incidence and computed tomographic findings. Surg Neurol 1985;24:671–676.
Ellenbogen RG, Winston KR, Kupsky WJ. Tumors of the choroid plexus in children. Neurosurgery 1989; 25(3); 397–335.
Sato T, Takeichi M, Abe M, Tabuchi K, Hara T. Frontal lobe tumor associated with late-onset seizure and psychosis: a case report. Jpn J Psychiatry Neurol 1993;47:541–544.
Ettinger A. Structural causes of epilepsy. Tumors, cysts, stroke, and vascular malformations. Neurol Clin 1994;12:41–56.
McKinney R, Debanne D, Gahwiler BH, et al. Lesion induced axonal sprouting and hyperexcitability in the hippocampus in vitro. Implications for the genesis of posttraumatic epilepsy. Nat Med 1997;3:990–996.
Gray W, Sundstrom LE. Kainic acid increases the proliferation of granule cell progenitors in the dentate gyrus of the rat. Brain Res 1998;790:52–59.
Echlin F. The supersensitivity of chronically “isolated” cerebral cortex as a mechanism in focal epilepsy. Electroencephalog Clin Neurophysiol 1959;11:697–732.
Patt S, Labrakakis C, Bernstein M, et al. Neuron-like physiological properties of cells from human oligodendroglial tumors. Neuroscience 1996; 71:601–611.
Labrakakis C, Patt S, Weydt P, et al. Action potential generating cells in human glioblastoma. J Neuropathol Exp Neurol 1997;56:243–254.
Goldstein D, Nadi NS, Stull R, Wyler AR, Porter RJ. Levels of catechols in epileptogenic and nonepileptogenic regions of the human brain. J Neurochem 1988;50:225–229.
Kish S, Dixon LM, Sherwin AL. Aspartic acid aminotransferase activity is increased in actively spiking compared with non-spiking cortex. J Neurol Neurosurg Psychiatry 1988;51:552–556.
Sherwin A, Vernet O, Dubeau F, Olivier A. Biochemical markers of excitability in human neocortex. Can J Neurol Sci 1991;18:640–644.
Avoli M, Drapeau C, Pumain R, Olivier A, Villemure J-G. Epileptiform activity induced by low extracellular magnesium in the human cortex maintained in vitro. Ann Neurol 1991;30:589–596.
Okada Y, Kloiber O, Hossman KA. Regional metabolism in experimental brain tumors in cats: relationship with acid/base, water and electrolyte homeostasis. J Neurosurg 1992;77:917–926.
Alger J, Frank JA, Bizzi A, et al. Metabolism of human gliomas: assessment with H-1 MR spectroscopy and F-18 fluorodeoxyglucose PET. Radiology 1990;177:633–641.
Neuwelt E, Goldman DL, Dahlborg SA, et al. Primary CNS lymphoma treated with osmotic blood-brain barrier disruption: prolonged survival and preservation of cognitive function. J Clin Oncol 1991;9:1580–1590.
Lukovits TG, Fadul CE, Pipas JM, Williamson PD. Nonconvulsive status epilepticus after intravenous contrast medium administration. Epilepsia 1996;37:1117–1120.
van de Loosdrecht AA, Gietema JA, van der Graaf WT. Seizures in a patient with disseminated testicular cancer due to cisplatin-induced hypomagnesaemia. Acta Oncol 2000;39:239–240.
McDonald GA, Dubose TD, Jr. Hyponatremia in the cancer patient. Oncology (Huntington) 1993;7: 55–64; discussion 67,68,70,71.
Meropol NJ, Creaven PJ, Petrelli NJ, White RM, Arbuck SG. Seizures associated with leucovorin administration in cancer patients. J Natl Cancer Inst 1995;87:56–58.
Delanty N, Vaughan CJ, French JA. Medical causes of seizures. Lancet 1998;352:383–390.
Dalmau J, Graus F, Rosenblum MK, Posner JB. Anti-Hu-associated paraneoplastic encephalomyelitis/sensory neuronopathy. A clinical study of 71 patients. Medicine (Baltimore) 1992;71:59–72.
Drislane FW. Nonconvulsive status epilepticus in patients with cancer. Clin Neurol Neurosurg 1994; 96:314–318.
Cocito L, Audenino D, Primavera A. Altered mental state and nonconvulsive status epilepticus in patients with cancer. Arch Neurol 2001;58:1310.
Jordan KG. Nonconvulsive status epilepticus in acute brain injury. J Clin Neurophysiol 1999;16: 332–340; discussion 353.
Jordan KG. Continuous EEG monitoring in the neuroscience intensive care unit and emergency department. J Clin Neurophysiol 1999;16:14–39.
Primavera A, Audenino D, Cocito L. Ifosfamide encephalopathy and nonconvulsive status epilepticus. Can J Neurol Sci 2002;29:180–193.
Glantz MJ, Cole BF, Forsyth PA, et al. Practice parameter: anticonvulsant prophylaxis in patients with newly diagnosed brain tumors. Report of the Quality Standards Subcommittee of the American Academy of Neurology. Neurology 2000;54:1886–1893.
Schaller B, Ruegg SJ. Brain tumor and seizures: pathophysiology and its implications for treatment revisited. Epilepsia 2003;44:1223–1232.
Cockey GH, Amann ST, Reents SB, Lynch JW, Jr. Stevens-Johnson syndrome resulting from whole-brain radiation and phenytoin. Am J Clin Oncol 1996;19:32–34.
Glantz MJ, Cole BF, Friedberg MH, et al. A randomized, blinded, placebo-controlled trial of divalproex sodium prophylaxis in adults with newly diagnosed brain tumors. Neurology 1996;46:985–991.
Deutschman C, Haines SJ. Anticonvulsant prophylaxis in neurological surgery. Neurosurgery 1985;17: 510–516.
Lee S, Lui TN, Chang CN, Cheng WC, Wang DJ, Heimbarger RF, Lin CG. Prophylactic anticonvulsants for prevention of immediate and early postcraniotomy seizures. Surg Neurol 1989;31:361–364.
Foy PM, Chadwick DW, Rajgopalan N, Johnson AL, Shaw MD. Do prophylactic anticonvulsant drugs alter the pattern of seizures after craniotomy? J Neurol Neurosurg Psychiatry 1992;55:753–757.
Beenen LF, Lindeboom J, Kasteleijn-Nolst Trenite DG, et al. Comparative double blind clinical trial of phenytoin and sodium valproate as anticonvulsant prophylaxis after craniotomy: efficacy, tolerability, and cognitive effects. J Neurol Neurosurg Psychiatry 1999;67:474–480.
Kuijlen JM, Teernstra OP, Kessels AG, Herpers MJ, Beuls EA. Effectiveness of antiepileptic prophylaxis used with supratentorial craniotomies: a meta-analysis. Seizure 1996;5:291–298.
Franceschetti S, Binelli S, Casazza M, et al. Influence of surgery and antiepileptic drugs on seizures symptomatic of cerebral tumours. Acta Neurochir (Wien) 1990;103:47–51.
Forsyth PA, Weaver S, Fulton D, et al. Prophylactic anticonvulsants in patients with brain tumour. Can J Neurol Sci 2003;30:106–112.
Hung S, Hilsenbeck S, Feun L. Seizure prophylaxis with phenytoin in patients with brain metastasis. Proc Am Soc Clin Oncol 1991;10:327.
Patsalos PN, Froscher W, Pisani F, van Rijn CM. The importance of drug interactions in epilepsy therapy. Epilepsia 2002;43:365–385.
Sylvester RK, Lewis FB, Caldwell KC, Lobell M, Perri R, Sawchuk RA. Impaired phenytoin bioavailability secondary to cisplatinum, vinblastine, and bleomycin. Ther Drug Monit 1984;6:302–305.
Neef C, de Voogd-van der Straaten I. An interaction between cytostatic and anticonvulsant drugs. Clin Pharmacol Ther 1988;43:372–375.
Gattis WA, May DB. Possible interaction involving phenytoin, dexamethasone, and antineoplastic agents: a case report and review. Ann Pharmacother 1996;30:520–526.
Bittigau P, Sifringer M, Genz K, et al. Antiepileptic drugs and apoptotic neurodegeneration in the developing brain. Proc Natl Acad Sci USA 2002;99:15,089–15,094.
Blaheta RA, Cinatl J, Jr. Anti-tumor mechanisms of valproate: a novel role for an old drug. Med Res Rev 2002;22:492–511.
Bardana EJ, Jr, Gabourel JD, Davies GH, Craig S. Effects of phenytoin on man’s immunity. Evaluation of changes in serum immunoglobulins, complement, and antinuclear antibody. Am J Med 1983;74:289–296.
Kikuchi K, McCormick CI, Neuwelt EA. Immunosuppression by phenytoin: implication for altered immune competence in brain-tumor patients. J Neurosurg 1984;61:1085–1090.
Weissman DE. Glucocorticoid treatment for brain metastases and epidural spinal cord compression: a review. J Clin Oncol 1988;6:543–551.
Guttuso T, Jr, Roscoe J, Griggs J. Effect of gabapentin on nausea induced by chemotherapy in patients with breast cancer. Lancet 2003;361:1703–1705.
Eralp Y, Aydiner A, Tas F, Saip P, Topuz E. Stevens-Johnson syndrome in a patient receiving anticonvulsant therapy during cranial irradiation. Am J Clin Oncol 2001;24:347–350.
Esteve E, Favre A, Martin L. Post-radiotherapy eruption in a patient treated with valproic acid. Rowell’s syndrome? Ann Dermatol Venereol 2002;129:901–903.
Mamon HJ, Wen PY, Burns AC, Loeffler JS. Allergic skin reactions to anticonvulsant medications in patients receiving cranial radiation therapy. Epilepsia 1999;40:341–344.
Smith DF, Hutton JL, Sandemann D, et al. The prognosis of primary intracerebral tumours presenting with epilepsy: the outcome of medical and surgical management. J Neurol Neurosurg Psychiatry 1991;54:915–920.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc., Totowa, NJ
About this chapter
Cite this chapter
Papavassiliou, E., Varelas, P.N. (2005). Brain Tumors and ICU Seizures. In: Varelas, P.N. (eds) Seizures in Critical Care. Current Clinical Neurology. Humana Press. https://doi.org/10.1007/978-1-59259-841-0_4
Download citation
DOI: https://doi.org/10.1007/978-1-59259-841-0_4
Publisher Name: Humana Press
Print ISBN: 978-1-58829-342-8
Online ISBN: 978-1-59259-841-0
eBook Packages: MedicineMedicine (R0)